VINORELBINE AN vinorelbine (as tartrate) 10 mg/1 mL concentrated injection vial

Active ingredient:

vinorelbine tartrate, Quantity: 13.85 mg (Equivalent: vinorelbine, Qty 10 mg)

Available from:

Amneal Pharma Australia Pty Ltd

INN (International Name):

Vinorelbine tartrate

Pharmaceutical form:

Injection, concentrated

Composition:

Excipient Ingredients: water for injections

Administration route:

Intravenous Infusion

Units in package:

Pack of 1 x 1 mL vial, Pack of 10 x 1 mL vials, Pack of 5 x 1 mL vials

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Product summary:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2012-01-18